|
2025-03-18 |
2025-03-17 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
2 500
-1.4%
110,53
276 325 USD
|
2 500
-1.4%
|
110,53
|
276 325 USD
|
|
|
2025-03-12 |
2025-03-10 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
13 013
-7.1%
118,50
1 542 055 USD
|
13 013
-7.1%
|
118,50
|
1 542 055 USD
|
|
|
2025-03-12 |
2025-03-10 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
4 916
-2.6%
117,30
576 641 USD
|
4 916
-2.6%
|
117,30
|
576 641 USD
|
|
|
2025-02-19 |
2025-02-18 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
2 500
-1.5%
104,09
260 225 USD
|
2 500
-1.5%
|
104,09
|
260 225 USD
|
|
|
2025-02-13 |
2025-02-12 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
137 676
-44.6%
102,22
14 073 241 USD
|
137 676
-44.6%
|
102,22
|
14 073 241 USD
|
|
|
2025-02-03 |
2025-01-31 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
142 180
-52.3%
97,22
13 822 740 USD
|
142 180
-52.3%
|
97,22
|
13 822 740 USD
|
|
|
2025-01-16 |
2025-01-15 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
2 500
-1.9%
91,35
228 375 USD
|
2 500
-1.9%
|
91,35
|
228 375 USD
|
|
|
2024-12-17 |
2024-12-16 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
8 500
-6.0%
91,96
781 660 USD
|
8 500
-6.0%
|
91,96
|
781 660 USD
|
|
|
2024-12-03 |
2024-11-29 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
127 930
-47.9%
92,76
11 867 119 USD
|
127 930
-47.9%
|
92,76
|
11 867 119 USD
|
|
|
2024-12-03 |
2024-11-29 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
120 715
-31.1%
92,77
11 198 151 USD
|
120 715
-31.1%
|
92,77
|
11 198 151 USD
|
|
|
2024-11-29 |
2024-11-27 |
V
Vente
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
10 399
-11.4%
92,00
956 708 USD
|
10 399
-11.4%
|
92,00
|
956 708 USD
|
|
|
2024-11-29 |
2024-11-27 |
V
Vente
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
3 199
-3.4%
91,80
293 679 USD
|
3 199
-3.4%
|
91,80
|
293 679 USD
|
|
|
2024-11-29 |
2024-11-27 |
V
Vente
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
5 200
-5.2%
91,80
477 381 USD
|
5 200
-5.2%
|
91,80
|
477 381 USD
|
|
|
2024-11-29 |
2024-11-27 |
V
Vente
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
88 119
-46.9%
92,00
8 106 948 USD
|
88 119
-46.9%
|
92,00
|
8 106 948 USD
|
|
|
2024-11-29 |
2024-11-27 |
V
Vente
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
57 294
-23.4%
91,79
5 259 297 USD
|
57 294
-23.4%
|
91,79
|
5 259 297 USD
|
|
|
2024-11-27 |
2024-11-26 |
V
Vente
|
Bluestone Jeffrey
Administrateur non-exécutif
|
6 788
-43.2%
91,39
620 356 USD
|
6 788
-43.2%
|
91,39
|
620 356 USD
|
|
|
2024-11-07 |
2024-11-06 |
VP
Vente planifiée
|
Mercier Johanna
Chief Commercial Officer
Dirigeant
|
5 000
-6.4%
91,28
456 400 USD
|
5 000
-6.4%
|
91,28
|
456 400 USD
|
|
|
2024-11-07 |
2024-11-06 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
5 000
-4.8%
91,50
457 500 USD
|
5 000
-4.8%
|
91,50
|
457 500 USD
|
|
|
2024-11-07 |
2024-11-06 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
20 590
-16.4%
91,50
1 883 985 USD
|
20 590
-16.4%
|
91,50
|
1 883 985 USD
|
|
|
2024-10-02 |
2024-10-01 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
2 000
-2.0%
83,83
167 660 USD
|
2 000
-2.0%
|
83,83
|
167 660 USD
|
|
|
2024-09-13 |
2024-09-12 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
21 246
-17.2%
84,50
1 795 287 USD
|
21 246
-17.2%
|
84,50
|
1 795 287 USD
|
|
|
2024-09-13 |
2024-09-12 |
VP
Vente planifiée
|
Mercier Johanna
Chief Commercial Officer
Dirigeant
|
13 432
-14.7%
83,25
1 118 214 USD
|
13 432
-14.7%
|
83,25
|
1 118 214 USD
|
|
|
2024-09-13 |
2024-09-12 |
VP
Vente planifiée
|
Mercier Johanna
Chief Commercial Officer
Dirigeant
|
15 925
-14.8%
84,23
1 341 363 USD
|
15 925
-14.8%
|
84,23
|
1 341 363 USD
|
|
|
2024-08-29 |
2024-08-28 |
VP
Vente planifiée
|
Mercier Johanna
Chief Commercial Officer
Dirigeant
|
9 513
-8.3%
78,03
742 299 USD
|
9 513
-8.3%
|
78,03
|
742 299 USD
|
|
|
2024-08-14 |
2024-08-13 |
VP
Vente planifiée
|
Mercier Johanna
Chief Commercial Officer
Dirigeant
|
5 490
-4.6%
73,98
406 150 USD
|
5 490
-4.6%
|
73,98
|
406 150 USD
|
|
|
2024-07-01 |
2024-07-01 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
2 000
-2.0%
68,63
137 260 USD
|
2 000
-2.0%
|
68,63
|
137 260 USD
|
|
|
2024-04-02 |
2024-04-01 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
2 000
-2.0%
72,96
145 920 USD
|
2 000
-2.0%
|
72,96
|
145 920 USD
|
|
|
2024-02-29 |
2024-02-29 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
8 230
-8.2%
72,74
598 624 USD
|
8 230
-8.2%
|
72,74
|
598 624 USD
|
|
|
2024-02-29 |
2024-02-28 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
2 000
-1.9%
73,18
146 360 USD
|
2 000
-1.9%
|
73,18
|
146 360 USD
|
|
|
2024-01-17 |
2024-01-16 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
5 000
-4.7%
85,78
428 900 USD
|
5 000
-4.7%
|
85,78
|
428 900 USD
|
|
|
2024-01-10 |
2024-01-09 |
VP
Vente planifiée
|
Mercier Johanna
Chief Commercial Officer
Dirigeant
|
8 242
-9.1%
85,23
702 466 USD
|
8 242
-9.1%
|
85,23
|
702 466 USD
|
|
|
2023-10-18 |
2023-10-17 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
5 000
-4.6%
80,00
400 017 USD
|
5 000
-4.6%
|
80,00
|
400 017 USD
|
|
|
2023-09-13 |
2023-09-12 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
1 501
-2.1%
76,99
115 562 USD
|
1 501
-2.1%
|
76,99
|
115 562 USD
|
|
|
2023-07-21 |
2023-07-20 |
VP
Vente planifiée
|
Dickinson Andrew D
Chief Financial Officer
Dirigeant
|
5 000
-4.4%
80,00
400 000 USD
|
5 000
-4.4%
|
80,00
|
400 000 USD
|
|
|
2023-06-14 |
2023-06-13 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
1 485
-4.8%
76,90
114 197 USD
|
1 485
-4.8%
|
76,90
|
114 197 USD
|
|
|
2023-03-14 |
2023-03-13 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
6 126
-8.0%
78,99
483 893 USD
|
6 126
-8.0%
|
78,99
|
483 893 USD
|
|
|
2023-03-02 |
2023-03-01 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
12 984
-15.6%
79,96
1 038 225 USD
|
12 984
-15.6%
|
79,96
|
1 038 225 USD
|
|
|
2023-01-03 |
2022-12-30 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
553
-1.2%
85,33
47 187 USD
|
553
-1.2%
|
85,33
|
47 187 USD
|
|
|
2022-11-10 |
2022-11-09 |
V
Vente
|
Wilfong Diane E.
SVP, Controller & CAO
Dirigeant
|
6 416
-18.5%
83,50
535 736 USD
|
6 416
-18.5%
|
83,50
|
535 736 USD
|
|
|
2022-11-02 |
2022-11-01 |
V
Vente
|
Wilfong Diane E.
SVP, Controller & CAO
Dirigeant
|
16 255
-36.5%
79,25
1 288 209 USD
|
16 255
-36.5%
|
79,25
|
1 288 209 USD
|
|
|
2022-03-14 |
2022-03-11 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
3 634
-10.0%
58,24
211 644 USD
|
3 634
-10.0%
|
58,24
|
211 644 USD
|
|
|
2022-02-11 |
2022-02-09 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
1 691
-4.9%
63,89
108 038 USD
|
1 691
-4.9%
|
63,89
|
108 038 USD
|
|
|
2022-02-02 |
2022-02-01 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
14 061
-30.1%
68,54
963 682 USD
|
14 061
-30.1%
|
68,54
|
963 682 USD
|
|
|
2021-05-05 |
2021-05-04 |
V
Vente
|
Mercier Johanna
Chief Commercial Officer
Dirigeant
|
19 496
-70.7%
66,09
1 288 547 USD
|
19 496
-70.7%
|
66,09
|
1 288 547 USD
|
|
|
2021-05-04 |
2021-05-03 |
V
Vente
|
Whitley Richard James
Administrateur non-exécutif
|
20 282
-39.5%
64,57
1 309 655 USD
|
20 282
-39.5%
|
64,57
|
1 309 655 USD
|
|
|
2021-03-12 |
2021-03-11 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
1 486
-4.8%
63,36
94 153 USD
|
1 486
-4.8%
|
63,36
|
94 153 USD
|
|
|
2021-02-11 |
2021-02-10 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
1 975
-6.4%
67,41
133 135 USD
|
1 975
-6.4%
|
67,41
|
133 135 USD
|
|
|
2021-02-03 |
2021-02-01 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
9 711
-25.2%
65,97
640 633 USD
|
9 711
-25.2%
|
65,97
|
640 633 USD
|
|
|
2020-08-19 |
2020-08-17 |
VP
Vente planifiée
|
Parsey Merdad
Chief Medical Officer
Dirigeant
|
182
-100.0%
68,32
12 434 USD
|
182
-100.0%
|
68,32
|
12 434 USD
|
|
|
2020-06-25 |
2020-06-23 |
V
Vente
|
Rodriguez Javier
Administrateur non-exécutif
|
189
-100.0%
75,50
14 270 USD
|
189
-100.0%
|
75,50
|
14 270 USD
|
|
|
2020-05-07 |
2020-05-05 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
13 210
-47.4%
79,23
1 046 640 USD
|
13 210
-47.4%
|
79,23
|
1 046 640 USD
|
|
|
2020-05-06 |
2020-05-04 |
V
Vente
|
Wilfong Diane E.
SVP, Controller & CAO
Dirigeant
|
12 264
-51.8%
80,09
982 220 USD
|
12 264
-51.8%
|
80,09
|
982 220 USD
|
|
|
2020-05-05 |
2020-05-04 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 416
-4.2%
81,75
197 508 USD
|
2 416
-4.2%
|
81,75
|
197 508 USD
|
|
|
2020-04-29 |
2020-04-27 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
79,90
192 799 USD
|
2 413
-4.2%
|
79,90
|
192 799 USD
|
|
|
2020-04-21 |
2020-04-20 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
83,00
200 279 USD
|
2 413
-4.2%
|
83,00
|
200 279 USD
|
|
|
2020-04-14 |
2020-04-13 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
75,90
183 147 USD
|
2 413
-4.2%
|
75,90
|
183 147 USD
|
|
|
2020-04-07 |
2020-04-06 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
79,52
191 882 USD
|
2 413
-4.2%
|
79,52
|
191 882 USD
|
|
|
2020-03-31 |
2020-03-30 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
75,35
181 820 USD
|
2 413
-4.2%
|
75,35
|
181 820 USD
|
|
|
2020-03-24 |
2020-03-23 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
75,27
181 627 USD
|
2 413
-4.2%
|
75,27
|
181 627 USD
|
|
|
2020-03-17 |
2020-03-16 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
67,26
162 298 USD
|
2 413
-4.2%
|
67,26
|
162 298 USD
|
|
|
2020-03-12 |
2020-03-10 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
2 950
-16.8%
75,55
222 873 USD
|
2 950
-16.8%
|
75,55
|
222 873 USD
|
|
|
2020-03-10 |
2020-03-09 |
V
Vente
|
Cogan John Francis
Administrateur non-exécutif
|
2 413
-4.2%
77,97
188 142 USD
|
2 413
-4.2%
|
77,97
|
188 142 USD
|
|
|
2020-03-03 |
2020-03-02 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
1 100
-7.0%
71,26
78 383 USD
|
1 100
-7.0%
|
71,26
|
78 383 USD
|
|
|
2020-03-03 |
2020-03-02 |
VP
Vente planifiée
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
9 341
-37.2%
70,83
661 631 USD
|
9 341
-37.2%
|
70,83
|
661 631 USD
|
|
|
2020-02-12 |
2020-02-10 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
2 950
-10.7%
69,32
204 494 USD
|
2 950
-10.7%
|
69,32
|
204 494 USD
|
|
|
2020-02-11 |
2020-02-10 |
V
Vente
|
WILSON GAYLE E
Administrateur non-exécutif
|
21 720
-14.6%
67,72
1 470 878 USD
|
21 720
-14.6%
|
67,72
|
1 470 878 USD
|
|
|
2020-02-10 |
2020-02-07 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
1 426
-5.5%
70,00
99 820 USD
|
1 426
-5.5%
|
70,00
|
99 820 USD
|
|
|
2020-02-10 |
2020-02-07 |
V
Vente
|
WOLD OLSEN PER
Administrateur non-exécutif
|
20 282
-17.2%
69,00
1 399 458 USD
|
20 282
-17.2%
|
69,00
|
1 399 458 USD
|
|
|
2020-02-10 |
2020-02-06 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
5 000
-16.8%
68,18
340 901 USD
|
5 000
-16.8%
|
68,18
|
340 901 USD
|
|
|
2020-02-10 |
2020-02-06 |
V
Vente
|
WOLD OLSEN PER
Administrateur non-exécutif
|
21 720
-18.2%
68,12
1 479 605 USD
|
21 720
-18.2%
|
68,12
|
1 479 605 USD
|
|
|
2020-01-06 |
2020-01-03 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
|
2 950
-14.7%
64,63
190 659 USD
|
2 950
-14.7%
|
64,63
|
190 659 USD
|
|
|
2019-12-04 |
2019-12-03 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
5 900
-25.7%
65,77
388 043 USD
|
5 900
-25.7%
|
65,77
|
388 043 USD
|
|
|
2019-11-26 |
2019-11-25 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
Dirigeant
|
15 000
-46.8%
66,85
1 002 809 USD
|
15 000
-46.8%
|
66,85
|
1 002 809 USD
|
|
|
2019-11-20 |
2019-11-19 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
|
10 000
-36.9%
64,91
649 062 USD
|
10 000
-36.9%
|
64,91
|
649 062 USD
|
|
|
2019-11-20 |
2019-11-18 |
V
Vente
|
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
|
10 000
-36.9%
63,85
638 500 USD
|
10 000
-36.9%
|
63,85
|
638 500 USD
|
|
